Scientist at NIAID reviews the escalating global prevalence of the MPX virus, detailing its biology and transmission modes, and the urgent need for comprehensive research to understand and control its spread effectively.
Evotec shuts down gene therapy business in light of Q1 2024 loss – Pharmaceutical Technology
Evotec’s group revenues decreased by 2% compared to the same period last year, excluding currency effects, to €208.7m ($226.6m) as per Evotec’s latest Q1 2024